NCT06008106 2024-06-28Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant MelanomaShanghai Kechow Pharma, Inc.Phase 3 Recruiting165 enrolled
NCT00111007 2014-10-31A Treatment Combination for Patients With Unresectable Stage III or Stage IV MelanomaBayerPhase 3 Completed270 enrolled 15 charts